search

Active clinical trials for "Osteoporosis, Postmenopausal"

Results 211-220 of 295

Patient- and Physician-Based Osteoporosis Education

OsteoporosisOsteoporosis1 more

Osteoporosis is an important public health problem. Osteoporosis can cause serious health complications and death and leads to increased medical costs. The purpose of this study is to identify an effective method of educating patients and health care professionals about the diagnosis and treatment of osteoporosis.

Completed4 enrollment criteria

Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults

Low Bone DensityOsteopenia2 more

No clinical trials have evaluated strontium L-lactate (SrLac), the strontium salt of the L-enantiomer of lactic acid. Therefore, this clinical study was conducted to obtain general safety and pharmacokinetic (PK) information following acute oral intakes of three doses of SrLac by healthy adults. The data provided valuable comparisons with the pharmacokinetics of other strontium salts that are in clinical use and allowed determination of the dose of SrLac that will be useful for the management of bone health.neficial for the treatment of low bone density of osteoporosis and osteopenia.

Completed25 enrollment criteria

Milk Protein and Bone Health in Postmenopausal Women

Bone and BonesOsteoporosis Risk2 more

The process of bone remodeling exhibits pronounced diurnal pattern that is important for bone health. A balanced rate of bone resorption is required to maintain bone health, a balance that can be disturbed during the life-cycle to effect net rate of formation (as occurs during growth and development to adulthood) or net resorption (as occurs, for example, during the menopause). Bone turnover is a nutritionally modulated process and the investigators believe a milk-based protein supplement (MBPS) can modulate beneficially the rate of bone resorption over the time period when bone remodeling is most active i.e. late evening/overnight. In this novel approach to the timing of nutrient ingestion, the proposed nutrient intervention seeks to modify (reduce) the rate of bone resorption and promote the rate of bone formation to the benefit of bone health in this at risk population..

Completed2 enrollment criteria

A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously...

Low Bone MassLow Bone Mineral Density2 more

To evaluate the combined effect of denosumab treatment and discontinuation on cortical thickness at the distal radius by High Resolution-Peripheral Quantitative Computed Tomography (HR-pQCT). Participants randomized to either denosumab or placebo in the 20050179 (NCT00293813) study who completed that study (ie, attended an end of study visit) can be included in this study. At least 12 months should have elapsed since the patient's 20050179 end of study visit.

Completed18 enrollment criteria

Strength Training for Older Breast Cancer Survivors

Breast NeoplasmOsteoporosis1 more

Women aged 50 and older are disproportionately affected by breast cancer, not only in terms of new diagnoses, but also in terms of survivorship. Approximately 85% of women who receive a first diagnosis of breast cancer are aged 50 and over, thus older women constitute the largest group of breast cancer survivors. Yet, few studies have focused on evaluating whether physical activity and exercise interventions affect long-term symptoms, physical fitness and function, and body composition of older breast cancer survivors. Due to the combined effects of breast cancer, related treatments and aging it is likely that exercise is even more beneficial for older breast cancer survivors than for younger survivors. Along with the cancer-related symptom of fatigue common to cancer survivors, older survivors face age-related declines in bone and muscle mass, muscle strength, bone health and physical function (gait and balance) that are likely exacerbated by reduced physical activity in survivorship and side effects of adjuvant cancer treatment. All women, regardless of age, are at risk for breast cancer recurrence. Recent epidemiologic evidence suggests a link between exercise and reduced risk of cancer recurrence in breast cancer survivors. Strength training is specifically suited to reverse or slow age-related declines in bone, muscle, strength and function and has shown promise to reduce cancer-related fatigue. However, no controlled trials of strength training in older breast cancer survivors have been conducted.

Completed7 enrollment criteria

Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis....

Postmenopausal Osteoporosis

Dose-response in Japanese patients with postmenopausal osteoporosis.

Completed2 enrollment criteria

A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants

OsteoporosisPostmenopausal

The purpose(s) of this study is to measure how much of the study drug gets into the blood stream and how long it takes the body to get rid of it when given in multiple doses, subcutaneously (SC) (by inserting a needle just under the surface of the skin in the lower abdominal area), to postmenopausal (PMP) female participants. Information about any side effects that may occur will also be collected. This study will also be looking for special markers called "biomarkers" that can be used to study osteoporosis and/or the effects of the study drug. There will be 2 parts to this study. The first part will last approximately 6 weeks and the second part will last approximately 7 weeks.

Completed8 enrollment criteria

Moringa Oleifera on Bone Density

OsteoporosisOsteopenia1 more

The purpose of this study is to determine the effects of Moringa Oleifera on the structure and function of bone in post-menopausal women ingesting 1000 mg of Moringa Oleifera daily for 12 weeks.

Completed6 enrollment criteria

The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation

Bone Loss

The objective of the study is to demonstrate the effects that lasofoxifene has on serum markers of bone metabolism.

Completed2 enrollment criteria

Safety Study of an Oral Vitamin D Analog in Postmenopausal Women

Postmenopausal OsteoporosisMultiple Sites

Determine the safety of 2MD, a vitamin D analog, when administered orally once daily for 28 days in healthy normal postmenopausal women.

Completed21 enrollment criteria
1...212223...30

Need Help? Contact our team!


We'll reach out to this number within 24 hrs